○Takehiro Ogawa¹, Takeo Iwata¹, Kikuji Yamashita¹, Yoshiko Tominaga² (1. Fac.Pharm, Niigata Univ. Pharm Applied Life Sci., 2. Collab Center Health Prom, Niigata Univ. Pharm Applied Life Sci.)

○Rina Odahara¹, Takahiro Nisi², Hiroko Yamakawa², Nobuhiro Nagasaki¹, Yuuko Saruhashi¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences , Fukuyama University, 2. Nisi Clinic)

○Naruho Sirakihara¹, Takahiro Nisi², Hiroko Yamakawa², Nobuhiro Nagasaki¹, Yuuko Saruhashi¹ (1. Faculty of Pharmacy and Pharmaceutical Sciences , Fukuyama University, 2. Nisi Clinic)

○Atsushi Shimada¹, Masaki Shoji¹, Atsuko Fujiwara², Mitsuko Onda¹ (1. Osaka University of Pharmaceutical Sciences , 2. Apis Pharmacy Co.Ltd)

○Kazuhide Ota¹, Yuto Akaba¹, Daigo Kasahara¹, Naotaka Son², Takeshi Kuwahara³, Koichi Masuyama¹, Kunihiko Kitagaki¹ (1. Tokyo University of Pharmacy and Life Sciences, 2. Pharmacy Inc., 3. Japanese Society of Hospital Pharmacists)

○Yuto Akaba¹, Masaki Narahara¹, Kazuhide Ota¹, Naotaka Son², Keiichi Chin¹, Takashi Kuwahara³, Koichi Masuyama¹, Kunihiko Kitagaki¹ (1. Tokyo University of Pharmacy and Life Sciences , 2. Pharmacy Inc., 3. Japanese Society of Hospital Pharmacists)

○Misuzu Tanabe¹, Takeo Iwata¹, Kikuji Yamashita¹, Yoshiko Tominaga² (1. Fac. Pharm, Niigata Univ. Pharm Applied Life Sci., 2. Collab Center Health Prom., Niigata Univ. Pharm Applied Life Sci.)

○Ayaka Sakurada¹, Noriko Kobayashi^1,2, Kazuko Fujimoto¹, Hiroki Iwata^1,2, Katsunori Yamaura^1,2 (1. Keio Univ Faculty Pharm, 2. Keio Univ Commun Pharm)

○Keiko (Sasaki) Akagawa¹, Norimi Kimura¹, Ryota Kumaki¹, Naomi Kurata¹, Keiko Kishimoto¹ (1. Division of Social Pharmacy , Showa Univ.)

○Mizuki Tanaka¹, Yukiha Tanaka¹, Chisayo Hakuno¹, Mayumi Sakaguchi¹ (1. Midori pharmacy)

○Yuka Horioka¹, Akihiro Michihara¹, Toshiya Sadamitsu¹, Aldo Sueda¹, Yukako Sunami¹ (1. Fukuyama Univ.)

○Shizuko Maeda¹, Mai Sasaki¹, Yoshitaka Tayama¹, Kazumi Sugihara¹, Katsushi Miyake¹ (1. Fac. Pharm. Sci.,Hiroshima Intl. Univ.)

○Kousuke Okamoto¹, Yu-Shi Tian², Tatsuya Takagi² (1. Faculty of Pharm. Sci., Hokuriku Univ., 2. Grad. School of Pharm. Sci., Osaka Univ.)

○Mikako Nakamura¹, Noriko Fukushima¹ (1. Social pharmacy.,Teikyouheisei Univ.)

○Takuma Yamashita¹, Yuki Naito², Takenori Yamamoto¹, Tokuyuki Yoshida¹, Takao Inoue¹, Eriko Uchida¹ (1. NIHS, 2. DBCLS)

○Jun-ichi Akagi¹, Young-Man Cho¹, Takeshi Toyoda¹, Yasuko Mizuta¹, Kumiko Ogawa¹ (1. Div. Pathol., Natl. Inst. Health Sci.)

○Akira Okada^1,2, Natsuko Takano¹, Shoji Sera^1,2, Naomi Nagai^1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)

○Yuta Nagashima¹, Akira Okada^1,2, Shoji Sera^1,2, Naomi Nagai^1,2 (1. Fac. Pharm., Musashino Univ., 2. Res. Ins. Pharm. Sci., Musashino Univ.)

○Tamaki Miyazaki¹, Hitomi Kanno¹, Daisuke Ando¹, Eiichi Yamamoto¹, Ken-ichi Izutsu¹ (1. Division of Drugs, NIHS)

○Takumi Akiyama¹, Yoshiaki Ikarashi¹ (1. Natl. Inst. Health Sci.)

○Akinori Shintani¹, Akira Hihara¹, Hiroaki Yamada¹ (1. YOKOHAMA UNIVERSITY OF PHARMACY)

○Yuko Kobuke¹, Kozue Imai³, Marina Tanaka¹, Toshio Kubota¹, Itsuko Horiguchi² (1. Daiichi Univ. Pharm., 2. Pharmaceut. Sci., Tokyo Univ.Science, 3. Former Japan Self-Medication Industry)

○Yuka Fukuda¹, Marika Uchida¹, Hideki Maeda¹ (1. Dept. Regulatory Science, Meiji Pharmaceutical University)

○Michiyuki Komiyama¹, Takayuki Miyazaki¹, Naoki Matsumaru¹, Katsura Tsukamoto¹ (1. Gifu Pharmaceutical Univ.)

○masanobu isoyama¹, makio kamida¹, yuka hukushima¹, tomoka nakamura², akira kitagawa², kazuo izumi², mayumi shikano¹ (1. Tokyo Univ. of Science Pharm, 2. National Center for Global Health and Medicine)

○Tetsu Kobayashi¹, Hiroko Shibata¹, Akiko Ishii¹ (1. NIHS)

○Kazuko Nishimura¹, Hiroko Shibata¹, Yoshiro Saito², Akiko Ishii-Watabe¹ (1. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 2. Division of Medicinal Safety Science, National Institute of Health Sciences)

○Hiroko Shibata¹, Kazuko Nishimura¹, Chizuru Miyama¹, Yoshiro Saito², Akiko Ishii-Watabe¹ (1. Division of Biological Chemistry and Biologicals, National Institute of Health Sciences, 2. Division of Medicinal Safety Science, National Institute of Health Sciences)

○Akiko Ishii-Watabe¹, Hiroko Shibata¹, Akira Harazono¹, Masashi Hyuga¹, Yukio Hiyama² (1. Division of Biological Chemistry and Biologicals, NIHS, 2. Division of Drugs, NIHS)

○Masashi Hyuga¹, Minoru Tada¹, Akiko Ishii-Watabe¹ (1. National Institute of Health Sciences)

○Akira Harazono¹, Hiroko Shibata¹, Akiko Ishii¹ (1. DBCB, NIHS)